Showing results (331-340 of 384) with videos related to
Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2014
Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 functionKerstin Wolk, Hiroshi Mitsui, Katrin Witte, et al.Plastic and Reconstructive Surgery|February 19, 2016
Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell LymphomaHonghua Hu, Khalid Johani, Ahmad Almatroudi, et al.Genes, Chromosomes & Cancer|May 23, 1998
Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomasG Ott, T Katzenberger, R Siebert, et al.Leukemia|April 18, 2002
Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group reportM S Cairo, M D Krailo, M Morse, et al.Blood|June 2, 2019
A novel model of controlling PD-L1 expression in ALK<sup>+</sup> anaplastic large cell lymphoma revealed by CRISPR screeningJing-Ping Zhang, Zhihui Song, Hong-Bo Wang, et al.Leukemia|November 13, 2020
A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphomaHongbo Wang, Wei Wei, Jing-Ping Zhang, et al.The Journal of Molecular Diagnostics : JMD|March 29, 2001
Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytesG K Przybylski, H Wu, W R Macon, et al.Human Pathology|April 25, 2018
IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesisMarshall E Kadin, John Morgan, Haiying Xu, et al.The American Journal of Pathology|August 1, 1996
CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissuesH J Gruss, A Pinto, A Gloghini, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma)T Rüdiger, E S Jaffe, G Delsol, et al.Pageof 39